Patents by Inventor Fabio Trento

Fabio Trento has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180256567
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Application
    Filed: March 16, 2018
    Publication date: September 13, 2018
    Inventors: Fabio TRENTO, Sergio CANTOREGGI, Giorgia ROSSI, Roberta CANNELLA, Daniele BONADEO
  • Patent number: 9943515
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: April 17, 2018
    Assignee: Helsinn Healthcare SA
    Inventors: Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo
  • Publication number: 20160136162
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Application
    Filed: January 21, 2016
    Publication date: May 19, 2016
    Applicant: Helsinn Healthcare SA
    Inventors: Fabio TRENTO, Sergio CANTOREGGI, Giorgia ROSSI, Roberta CANNELLA, Daniele BONADEO
  • Publication number: 20160067311
    Abstract: The invention relates to the use of elsiglutide to prevent or reduce the occurrence of gastrointestinal damage caused by chemotherapeutic agents, including gastrointestinal mucositis and chemotherapy-induced diarrhea (CID).
    Type: Application
    Filed: September 1, 2015
    Publication date: March 10, 2016
    Applicant: HELSINN HEALTHCARE SA
    Inventors: Ruben GIORGINO, Simona RONCORONI, Selma CALCAGNILE, Fabio TRENTO, Riccardo SPEZIA, Cecilia MORESINO
  • Patent number: 9271975
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: March 1, 2016
    Assignee: HELSINN HEALTHCARE SA
    Inventors: Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo
  • Patent number: 9186357
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: November 17, 2015
    Assignee: HELSINN HEALTHCARE SA
    Inventors: Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo
  • Patent number: 8951969
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: February 10, 2015
    Assignee: Helsinn Healthcare SA
    Inventors: Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo
  • Publication number: 20140194395
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Application
    Filed: November 1, 2013
    Publication date: July 10, 2014
    Applicant: Helsinn Healthcare S.A.
    Inventors: Fabio TRENTO, Sergio CANTOREGGI, Giorgia ROSSI, Roberta CANNELLA, Daniele BONADEO
  • Publication number: 20140194438
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Application
    Filed: November 1, 2013
    Publication date: July 10, 2014
    Applicant: Helsinn Healthcare S.A.
    Inventors: Fabio TRENTO, Sergio CANTOREGGI, Giorgia ROSSI, Roberta CANNELLA, Daniele BONADEO
  • Publication number: 20140193487
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Application
    Filed: November 1, 2013
    Publication date: July 10, 2014
    Applicant: Helsinn Healthcare S.A.
    Inventors: Fabio TRENTO, Sergio CANTOREGGI, Giorgia ROSSI, Roberta CANNELLA, Daniele BONADEO
  • Patent number: 8623826
    Abstract: Provided are methods for treating nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery, comprising the co-administration of netupitant, palonosetron and dexamethasone.
    Type: Grant
    Filed: March 31, 2011
    Date of Patent: January 7, 2014
    Assignee: Helsinn Healthcare S.A.
    Inventors: Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo
  • Publication number: 20120064153
    Abstract: Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
    Type: Application
    Filed: March 31, 2011
    Publication date: March 15, 2012
    Applicant: HELSINN HEALTHCARE SA
    Inventors: Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo, Riccardo Braglia
  • Patent number: 6767554
    Abstract: The invention relates to the use as medicaments, specifically as antiinflammatories, of complexes formed by cationic liposomes and polydeoxyribonucleotides having a molecular weight in the range 7,000-60,000 Da obtainable by depolymerization of nucleic acids, wherein in said complexes the polydeoxyribonucletoides are located on the outer surface of the liposome.
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: July 27, 2004
    Assignee: Gentum S.p.A.
    Inventors: Roberto Porta, Laura Ferro, Fabio Trento, Claudio Nastruzzi, Elisabetta Esposito, Enea Menegatti
  • Publication number: 20020142029
    Abstract: The invention relates to the use as medicaments, specifically as antiinflammatories, of complexes formed by cationic liposomes and polydeoxyribonucleotides having a molecular weight in the range 7,000-60,000 Da obtainable by depolymerization of nucleic acids, wherein in said complexes the polydeoxyribonucletoides are located on the outer surface of the liposome.
    Type: Application
    Filed: June 11, 1999
    Publication date: October 3, 2002
    Inventors: ROBERTO PORTA, LAURA FERRO, FABIO TRENTO, CLAUDIO NASTRUZZI, ELISABETTA ESPOSITO, ENEA MENEGATTI
  • Patent number: 5948405
    Abstract: Fucans with low molecular weight having anticoagulant, antithrombinic and antithrombotic activity.Fucan sulfates having molecular weight between 14000 and 29000 Dalton show a remarkable anticoagulant activity both in the global coagulation mechanism (APTT) and in the last phase of coagulation (antithrombinic activity). These compounds are useful also as antithrombotic drugs.
    Type: Grant
    Filed: December 18, 1997
    Date of Patent: September 7, 1999
    Assignee: Crinos Industria Farmacobiologica S.p.A.
    Inventors: Armando Cedro, Roberto Porta, Franco Cattaneo, Fabio Trento, Laura Ferro, Ennio Lanzarotti
  • Patent number: D665072
    Type: Grant
    Filed: September 8, 2011
    Date of Patent: August 7, 2012
    Assignee: Helsinn Healthcare S.A.
    Inventors: Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo, Riccardo Braglia